黃柏憲

Wang, H. C., Lin, Y. L., Hsu, C. C., Chao, Y. J., Hou, Y. C., Chiu, T. J., Huang, P. H., Tang, M. J., Chen, L. T. & Shan, Y. S., 2019 一月 1, 於 : Theranostics. 9, 24, p. 7168-7183 16 p.

研究成果: Article

開啟存取

Pancreatic Stellate Cells

Plasminogen Activator Inhibitor 1

Interleukin-8

Pancreatic Neoplasms

Up-Regulation

5 引文 (Scopus)

Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancer

Chuang, H. C., Huang, P-H., Kulp, S. K. & Chen, C. S., 2017 三月 1, 於 : Pharmacological Research. 117, p. 370-376 7 p.

研究成果: Review article

Pancreatic Neoplasms

Pharmacology

Nucleotide Motifs

History

Ligands

4 引文 (Scopus)

TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1

Huang, P. H., Lu, P. J., Ding, L. Y., Chu, P. C., Hsu, W. Y., Chen, C. S., Tsao, C. C., Chen, B. H., Lee, C. T., Shan, Y. S. & Chen, C. S., 2017 四月 20, 於 : Oncogene. 36, 16, p. 2202-2214 13 p.

研究成果: Article

Pancreatic Neoplasms

Epigenomics

Phenotype

Epithelial-Mesenchymal Transition

gemcitabine

7 引文 (Scopus)

Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42

Henderson, S. E., Ding, L. Y., Mo, X., Bekaii-Saab, T., Kulp, S. K., Chen, C. S. & Huang, P. H., 2016 一月 1, 於 : Neoplasia (United States). 18, 12, p. 765-774 10 p.

研究成果: Article

Histone Deacetylase Inhibitors

Pancreatic Neoplasms

Transgenic Mice

Muscles

Histone Deacetylases

11 引文 (Scopus)

Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism

Yang, Y. L., Huang, P. H., Chiu, H. C., Kulp, S. K., Chen, C. S., Kuo, C. J., Chen, H. D. & Chen, C. S., 2013 五月 24, 於 : Biochemical and Biophysical Research Communications. 435, 1, p. 107-112 6 p.

研究成果: Article

Histone Deacetylase Inhibitors

Telomerase

Human Activities

Glioma

Histone Deacetylases

黃 柏憲

學歷

研究專長

經歷

黃柏憲